HOPA's Practice Outcomes and Professional Benchmarking Committee (POPBC) conducted a multi-organization, voluntary survey of HOPA members between March of 2021 and January of 2022. The purpose was to better understand the landscape of oncology pharmacy at healthcare organizations throughout the United States.

The research examined: institutional description, job function, staffing, and training/certification. Data were evaluated using descriptive statistics. The analysis found that as the number of patients with cancer rises, the oncology workforce must grow. The current oncology pharmacy practice landscape can serve as a foundation for future research, metrics, and benchmarks.

This research was published in the Journal of Oncology Pharmacy Practice.


Authors: Shawn P Griffin, Jessie R Signorelli, Aubrey Lasko, Benjamin J Andrick, David Doan, Shannon Hough, Grazyna Riebandt, and Stephen Harnicar

HOPA logo
Advocacy

HOPA Issues Updated Drug Shortages Brief

Shortages of drugs that are essential for the treatment and care of individuals with cancer result in compromises to patient care and, ultimately, outcomes.

An oncology pharmacist helping a patient
Advocacy

Oncology Pharmacist Survey: Understanding Task Value and Professional Satisfaction

Recent publications have explored workload and productivity to improve oncology pharmacy practice. HOPA aimed to build upon that research by assessing task valuation.

An image of the Capitol building on a cloudless day
Advocacy

Congress Passes Health Extenders and PBM Reform

Here's what HOPA members should know about the end of the recent government shutdown, the resulting appropriations bills passed by Congress, and what the package includes pertaining to health care.